Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 3Peutz-Jeghers Syndrome 1Pancreatitis, Chronic 1Pancreatic Neoplasms 1Pancreatic Cyst 1Neoplasm Metastasis 1Lung Neoplasms 1Hip Fractures 1Glioma 1Glioblastoma 1Fractures, Spontaneous 1Financial Stress 1Dysplastic Nevus Syndrome 1Colorectal Neoplasms, Hereditary Nonpolyposis 1COVID-19 1Brain Neoplasms 1Bone Neoplasms 1Ataxia Telangiectasia 1

Interventions

Specimen Handling 45pembrolizumab 41Biopsy 37Magnetic Resonance Spectroscopy 35Nivolumab 21Paclitaxel 20Gemcitabine 20Radiosurgery 19Carboplatin 19Irinotecan 14Ipilimumab 13Cisplatin 12Capecitabine 12130-nm albumin-bound paclitaxel 12Taxes 11Pemetrexed 11trastuzumab deruxtecan 10olaparib 10Leucovorin 10Fluorouracil 10Oxaliplatin 9Fulvestrant 9Cyclophosphamide 9Cetuximab 9durvalumab 8abemaciclib 8X-Rays 8Drug Therapy 8Bevacizumab 8palbociclib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Data Collection × 90 days × Clear all
NCT04387656 2026-05-27

NCI COVID-19 in Cancer Patients, NCCAPS Study

National Cancer Institute (NCI)

Active not recruiting
1,877 enrolled

COVID-19, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡